The efficacy of continuous serratus anterior plane block for minimally invasive cardiac surgery: a randomized controlled trial.

Continuous serratus anterior plane block versus single block for quality of recovery scores in minimally invasive cardiac surgery: a prospective, randomized, placebo controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053197

Enrollment

Unknown

Registered

2021-11-14

Start date

2021-12-01

Completion date

Unknown

Last updated

2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control group:Serratus anterior plane catheterization, continuous analgesia with 0.9% sodium chloride after a single injection of ropivacaine

Experimental group:Serratus anterior plane catheterization, continuous analgesia with 0.2% ropivacaine after a single injection of ropivacaine

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. No gender restriction, aged between 18 and 80 years; 2. NYHA class I-III; 3. Body mass index (BMI) 18-31kg/m^2; 4. Elective minimally invasive cardiac surgery; 5. Voluntarily participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who participate in other clinical trials at the same time; 2. Patients with secondary surgery; 3. Left ventricular ejection fraction less than 50%; 4. Combined with coronary heart disease; 5. Active stage of infective endocarditis; 6. Chronic obstructive pulmonary disease or asthma; 7. Patients with preoperative liver and kidney insufficiency (ALT, AST, SCr or BUN increased to more than 1.5 times the normal value); 8. Preoperative chronic pain; 9. Known to abuse alcohol, drugs or narcotics; 10. Those who are known to be allergic to the drugs used in the study; 11. Dementia or preoperative mental disorder; 12. Patients who do not cooperate or cannot communicate; 13. Female patients who are pregnant or breastfeeding.

Design outcomes

Secondary

Measure	Time frame
Postoperative opioid consumption;Postoperative delirium;Postoperative nausea and vomiting;Time of postoperative mechanical ventilation;Time of ICU discharge;Duration of hospitalization;Complication rate;Numerical Rating Scale;Postoperative chronic pain;	—

Primary

Measure	Time frame
Quality of Recovery-15;	—

Countries

China

Contacts

Public ContactRen Yun

Zhongshan Hospital, Fudan University

cscazsry@outlook.com+86 13917802870

Outcome results